Carmen Burgaleta Selected Research

Carmen Burgaleta Research Topics

4	Thrombosis (Thrombus) 01/2017 - 08/2010
4	Essential Thrombocythemia 01/2016 - 06/2009
4	Neoplasms (Cancer) 01/2016 - 01/2003
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 11/2014
3	Polycythemia Vera 01/2017 - 02/2012
3	Infections 08/2009 - 01/2003
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016 - 08/2010
2	Hemorrhage 01/2016 - 08/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2014 - 09/2005
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2013 - 01/2007
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2011 - 08/2009
1	Sepsis (Septicemia) 01/2016
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 06/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2010
1	Human Influenza (Influenza) 03/2010
1	Pneumonia (Pneumonitis) 03/2010
1	Acute Kidney Injury (Acute Renal Failure) 12/2008
1	Progressive Multifocal Leukoencephalopathy 12/2005
1	Hodgkin Disease (Hodgkin's Disease) 12/2005
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2005
1	Communicable Diseases (Infectious Diseases) 12/2005
1	Hematologic Neoplasms (Hematological Malignancy) 09/2005
1	Peritonitis 09/2005
1	Fever (Fevers) 01/2003
1	Neutropenia 01/2003
1	Chemotherapy-Induced Febrile Neutropenia 01/2003
1	Lymphoma (Lymphomas) 06/2002
1	Hemolysis 06/2002

5	Rituximab (Mabthera)FDA Link 02/2013 - 12/2005
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2013 - 01/2007
3	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2017 - 02/2012
2	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 07/2015
2	Tyrosine Kinase InhibitorsIBA 07/2015 - 11/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2013 - 01/2007
2	Etoposide (VP 16)FDA LinkGeneric 02/2013 - 01/2007
2	Prednisone (Sone)FDA LinkGeneric 02/2013 - 01/2007
2	Vincristine (Oncovin)FDA LinkGeneric 02/2013 - 01/2007
2	fludarabineIBA 03/2011 - 08/2009
1	Patched-1 ReceptorIBA 01/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016
1	Ribosomal Proteins (Ribosomal Protein)IBA 06/2015
1	Busulfan (Busulfex)FDA Link 12/2014
1	Drug CombinationsIBA 08/2014
1	Dasatinib (BMS 354825)FDA Link 06/2013
1	ruxolitinibIBA 06/2013
1	KNK 437IBA 06/2013
1	Sorafenib (BAY 43-9006)FDA Link 06/2013
1	perifosineIBA 06/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2013
1	insulin receptor-related receptor (IRR)IBA 08/2010
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2010
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 08/2009
1	anagrelide (Agrylin)FDA LinkGeneric 06/2009
1	Methotrexate (Mexate)FDA LinkGeneric 12/2008
1	Alkylating AgentsIBA 12/2005
1	purineIBA 12/2005
1	Antineoplastic Agents (Antineoplastics)IBA 12/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2002

9	Therapeutics 01/2017 - 06/2002
4	Drug Therapy (Chemotherapy) 01/2016 - 01/2003
1	Catheters 01/2016
1	Precision Medicine 08/2014
1	Radiotherapy 12/2005
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 09/2005
1	Organ Transplantation 09/2005
1	Induction Chemotherapy 06/2002